Filing Details

Accession Number:
0001181431-14-037945
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-04 16:56:43
Reporting Period:
2014-12-02
Filing Date:
2014-12-04
Accepted Time:
2014-12-04 16:56:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
913165 Exactech Inc EXAC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 592603930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206762 J Gary Miller 531 Sw 26Th Place
Gainesville FL 32601
Executive Vice President, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-02 3,374 $12.68 24,980 No 4 M Direct
Common Stock Disposition 2014-12-02 3,374 $21.94 21,606 No 4 S Direct
Common Stock Acquisiton 2014-12-03 1,626 $12.68 23,232 No 4 M Direct
Common Stock Disposition 2014-12-03 1,626 $21.61 21,606 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Option (right to buy) Disposition 2014-12-02 3,374 $12.68 5,000 $12.68
Common Stock Non-Qualified Option (right to buy) Disposition 2014-12-03 1,626 $12.68 5,000 $12.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,626 2012-02-18 2015-02-18 No 4 M Direct
0 2012-02-18 2015-02-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 246,520 Indirect by Partnership
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Incentive Stock Option (right to buy) $14.12 2005-11-30 2015-05-09 10,000 10,000 Direct
Common Stock Non-Qualified Option (right to buy) $14.27 2011-12-18 2016-12-18 5,000 5,000 Direct
Common Stock Non-Qualified Option (right to buy) $17.02 2013-02-16 2016-02-16 16,000 16,000 Direct
Common Stock Non-Qualified Option (right to buy) $18.95 2014-02-28 2017-02-28 2,800 2,800 Direct
Common Stock Incentive Stock Option (right to buy) $16.33 2017-02-22 2019-02-22 19,800 19,800 Direct
Common Stock Incentive/Non-Qualified Option (right to buy) $18.55 2018-02-25 2020-02-25 16,000 16,000 Direct
Common Stock Non-Qualified Stock Option (right to buy) $20.90 2019-05-09 2021-05-09 12,000 12,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-05-09 10,000 10,000 Direct
2016-12-18 5,000 5,000 Direct
2016-02-16 16,000 16,000 Direct
2017-02-28 2,800 2,800 Direct
2019-02-22 19,800 19,800 Direct
2020-02-25 16,000 16,000 Direct
2021-05-09 12,000 12,000 Direct
Footnotes
  1. Such options are currently exercisable as regards 7,920 of the covered shares. The remaining options are exercisable, as regards 3,960 of the covered shares, on the third anniversary of the date of grant, as regards 3,960 of the covered shares on the fourth anniversary of the date of grant, and as regards 3,960 of the covered shares, on the fifth anniversary of the date of grant.
  2. Such options are currently exercisable as regards 3,200 of the covered shares. The remaining options are exercisable, as regards 3,200 of the covered shares, on the second anniversary of the date of grant, as regards 3,200 of the covered shares, on the third anniversary of the date of grant, as regards 3,200 of the covered shares on the fourth anniversary of the date of grant, and as regards 3,200 of the covered shares, on the fifth anniversary of the date of grant.
  3. Such options are exercisable as regards 2,400 of the covered shares, on the first anniversary of the date of grant, as regards 2,400 of the covered shares, on the second anniversary of the date of grant, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
  4. Such in-the-money options were exercised by the Reporting Person in lieu of allowing such options to expire by their terms on February 18, 2015.